Investors are hoping for a turnaround in the company's business prospects due to its high P/S ratio and poor growth rate. However, if recent medium-term revenue trends persist, the stock value may not be sustainable.
Despite medium-term revenue decline, high P/S ratio could disappoint shareholders if it aligns with declining growth. Potential investors should be wary of stock's overvaluation and overly bullish sentiments. Continuous decline could pose risk to investments.
Zhejiang Sunflower Great Health Stock Forum
No comment yet